(AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics; Is $34.50 a Fair Price?
- Monday, August 31, 2020, 6:44
- Finance
- Add a comment
SAN DIEGO, Aug. 31, 2020 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Aimmune Therapeutics, Inc. (“Aimmune” or the “Company”) (NASDAQ: AIMT) breached their fiduciary duties in connection with the proposed…
About the Author
adminasapcorp has written 37658 stories on this site.